As we move further into 2018, I am immensely pleased to pen this February 2018 edition of Oviya MedSafe’s newsletter! This edition aims to dwell upon one of Oviya MedSafe’s core values, namely ‘deep-rooted business integrity‘.
Integrity, at a personal level, could be defined as one’s strict adherence to a moral code, reflected in transparent honesty and complete harmony in what the person thinks, says, and does. At an organizational level too, the definition would remain pretty much the same, although achieving it might be much more difficult than it can be for an individual. While no organization would say that they do not value integrity and while many organizations explicitly claim to be high on integrity, the fact remains that only a few organizations have adequately and accurately imbibed the principles of integrity in order to practise it in thought, word and deed. Oviya MedSafe takes pride in being part of this league, thanks to integrity being an inseparable component of its roots.
KTVR Vijaydeepa Group, the Coimbatore-based conglomerate that holds the majority shareholding in Oviya MedSafe, was built upon the personal values of integrity carried by its founder Mr K T Venkatarama Reddy, a self-made entrepreneur who transformed his name into a well-respected brand during his lifetime. Our minority shareholder Ma Foi is a globally renowned name for its integrity. In fact, the very meaning of the French word ‘Ma Foi‘ is ‘My Word‘. Standing on the shoulders of these giants, it is quite natural that Oviya MedSafe has a flair for integrity, which is evidenced by the repetitive engagements our clients have done with us in the past 6 years.
As we all know, integrity is imperative in the pharmacovigilance domain. Throughout the life cycle of pharmacovigilance activities, especially in the industry, integrity has a key role to play. A single act of low integrity happening anywhere in the system may end up pulling down the system altogether. With quite a number of contract research organizations having earned dubious distinctions for being low on integrity, Oviya MedSafe aspires to stand tall as a lighthouse in practising global pharmacovigilance with uncompromising integrity levels, so much so that we have at times denied certain paid assignments despite our clients’ willingness to award them to us, for the simple reason that the said activity was not required for the particular client at that point of time. Such a straight-forward approach has only brought us more and more business, as it has improved our trustworthiness as an organization.
At Oviya MedSafe, integrity has always been important at all levels – beginning right from keeping the explicit and implicit promises we made to our clients as well as suppliers; to ensuring that all our team members absorb and emit our intensity of integrity. This organizational achievement has been possible only because we made a conscious decision as early as in 2012 (when we began our journey) to avoid all such unethical shortcuts even though they may have assured or even actually resulted in quick revenue. The bottom-line for us was, is and will be the fact that Oviya MedSafe is looking to be in pharmacovigilance, not just until it ceases to be a buzzword, but rather for life!
To sum up, let me use the words of Donald A. Adams: “To give real service, you must add something which cannot be bought or measured with money, and that is sincerity and integrity.”
I thank you for your patient reading and hope to meet many of you at DIA India’s 6th Pharmacovigilance Conference in which I am a Program Committee Member.
Eager to speak to you again through our March 2018 newsletter,
With thanks & regards,
Dr J Vijay Venkatraman
MBBS, F. Diab., MBA, FPIPA (UK)
Managing Director & CEO,
Oviya MedSafe Pvt Ltd,
Oviya MedSafe UK Ltd,
Follow us on: Facebook, LinkedIn & Twitter